Ophthalmology device manufacturer BVI (Waltham, Mass.) recently announced it has acquired Benz Research & Development and its customized contact lens subsidiary, SpecialEyes, both based in Sarasota, Florida.
A supplier of materials for BVI’s PhysIOL lens products, Benz specializes in molding hydrophobic and hydrophilic acrylic intraocular lenses (IOLs) with tight, nanometer tolerances. It is also one of only a few suppliers of raw materials for IOL production. Benz will continue to supply its materials to its customers following this deal, according to the companies.
The acquisition marks a period of significant expansion for BVI.
“Adding Benz to our company is quite strategic for BVI as it brings us world-class lens material capabilities,” said BVI president & CEO Shervin Korangy in a news release. “Furthermore, the proprietary IOL molding technology will allow us to increase materially the scale of our IOL production.”
“This deal marries the industry’s leading optical design and IOL platform with the industry’s best IOL material and production technology,” added Benz R&D founder and CEO Patrick Benz. “Benz has supplied PhysIOL lens production for many years, so we know what we are getting into. BVI’s vision of the future is incredibly exciting and will allow us to bring our technology to the next level.”
The financial terms of the deal were not disclosed.
